O
OrbiMed’s Evolent Health EVH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,665,115
| Closed | -$47.1M | – | 118 |
|
|
2024
Q3 | $47.1M | Sell |
1,665,115
-940,500
| -36% | -$26.6M | 0.86% | 35 |
|
|
2024
Q2 | $49.8M | Hold |
2,605,615
| – | – | 0.98% | 33 |
|
|
2024
Q1 | $85.4M | Sell |
2,605,615
-140,917
| -5% | -$4.62M | 1.56% | 20 |
|
|
2023
Q4 | $90.7M | Sell |
2,746,532
-149,100
| -5% | -$4.92M | 1.81% | 16 |
|
|
2023
Q3 | $78.8M | Hold |
2,895,632
| – | – | 1.67% | 20 |
|
|
2023
Q2 | $87.7M | Hold |
2,895,632
| – | – | 1.59% | 18 |
|
|
2023
Q1 | $94M | Buy |
2,895,632
+70,800
| +3% | +$2.3M | 1.84% | 15 |
|
|
2022
Q4 | $79.3M | Buy |
2,824,832
+830,115
| +42% | +$23.3M | 1.52% | 19 |
|
|
2022
Q3 | $71.7K | Buy |
1,994,717
+216,717
| +12% | +$7.79K | 1.33% | 26 |
|
|
2022
Q2 | $54.6K | Buy |
1,778,000
+378,000
| +27% | +$11.6K | 0.99% | 34 |
|
|
2022
Q1 | $45.2M | Buy |
1,400,000
+462,000
| +49% | +$14.9M | 0.73% | 43 |
|
|
2021
Q4 | $26M | Buy |
938,000
+593,000
| +172% | +$16.4M | 0.33% | 72 |
|
|
2021
Q3 | $10.7M | Buy |
+345,000
| New | +$10.7M | 0.12% | 124 |
|